Erich Bluhmki
Boehringer Ingelheim (Germany)(DE)University of Applied Sciences Biberach(DE)University of Edinburgh(GB)
Publications by Year
Research Areas
Acute Ischemic Stroke Management, Venous Thromboembolism Diagnosis and Management, Stroke Rehabilitation and Recovery, Cerebrovascular and Carotid Artery Diseases, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes(2015)11,755 cited
- → Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke(2008)6,558 cited
- → Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)(1998)3,615 cited
- → Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials(2014)2,680 cited
- → Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials(2004)2,550 cited
- → Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials